ASO Author Reflections: The Landmark Series—Neoadjuvant Therapy for Resectable Pancreatic Cancer

Esther N. Dekker; Ching Wei D. Tzeng

doi:10.1245/s10434-025-17835-3

ASO Author Reflections: The Landmark Series—Neoadjuvant Therapy for Resectable Pancreatic Cancer

Esther N. Dekker
, Ching Wei D. Tzeng^*

^*Corresponding author for this work

Surgery

University of Texas MD Anderson Cancer Center

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	6571-6572
Number of pages	2
Journal	Annals of Surgical Oncology
Volume	32
Issue number	9
DOIs	https://doi.org/10.1245/s10434-025-17835-3
Publication status	Published - Sept 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1245/s10434-025-17835-3

Cite this

@article{4360392effc14bdc9143a130ebf7bc80,

title = "ASO Author Reflections: The Landmark Series—Neoadjuvant Therapy for Resectable Pancreatic Cancer",

author = "Dekker, \{Esther N.\} and Tzeng, \{Ching Wei D.\}",

year = "2025",

month = sep,

doi = "10.1245/s10434-025-17835-3",

language = "English",

volume = "32",

pages = "6571--6572",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer Science+Business Media",

number = "9",

}

TY - JOUR

T1 - ASO Author Reflections

T2 - The Landmark Series—Neoadjuvant Therapy for Resectable Pancreatic Cancer

AU - Dekker, Esther N.

AU - Tzeng, Ching Wei D.

PY - 2025/9

Y1 - 2025/9

UR - https://www.scopus.com/pages/publications/105010592384

U2 - 10.1245/s10434-025-17835-3

DO - 10.1245/s10434-025-17835-3

M3 - Article

C2 - 40640481

AN - SCOPUS:105010592384

SN - 1068-9265

VL - 32

SP - 6571

EP - 6572

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

IS - 9

ER -

ASO Author Reflections: The Landmark Series—Neoadjuvant Therapy for Resectable Pancreatic Cancer

UN SDGs

Access to Document

Other files and links

Embargoed Document

Cite this